Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
13.39
+0.59 (4.61%)
Dec 3, 2025, 4:00 PM EST - Market closed

Alto Neuroscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
137.82168.2382.5548.3425.71
Cash & Short-Term Investments
137.82168.2382.5548.3425.71
Cash Growth
-24.15%103.79%70.75%88.07%-
Accounts Receivable
----1.5
Other Receivables
---0.330.25
Receivables
---0.331.74
Prepaid Expenses
1.631.080.520.330.24
Other Current Assets
-0.032.320.21-
Total Current Assets
139.45169.3485.3949.2227.68
Property, Plant & Equipment
6.497.71.231.581.06
Other Long-Term Assets
1.070.50.010.060.05
Total Assets
147.01177.5486.6350.8528.79
Accounts Payable
2.061.581.071.610.6
Accrued Expenses
5.877.563.53.670.93
Current Portion of Leases
1.120.870.130.28-
Other Current Liabilities
--0.92-0.28
Total Current Liabilities
9.0510.015.615.561.81
Long-Term Debt
20.3111.569.869.47-
Long-Term Leases
3.974.52-0.12-
Total Liabilities
35.4526.0815.4715.151.81
Common Stock
00--0
Additional Paid-In Capital
296.99289.955.372.30.49
Retained Earnings
-185.45-138.4-76.97-40.66-12.95
Comprehensive Income & Other
0.01-0.1-0.08-0.05-0.02
Total Common Equity
111.56151.46-71.67-38.41-12.48
Shareholders' Equity
111.56151.4671.1635.7126.98
Total Liabilities & Equity
147.01177.5486.6350.8528.79
Total Debt
25.416.949.999.87-
Net Cash (Debt)
112.42151.2972.5638.4725.71
Net Cash Growth
-32.37%108.49%88.61%49.67%-
Net Cash Per Share
4.166.1519.4511.1610.65
Filing Date Shares Outstanding
31.0727.0726.863.692.41
Total Common Shares Outstanding
27.1726.993.813.692.41
Working Capital
130.4159.3379.7843.6625.87
Book Value Per Share
4.115.61-18.81-10.40-5.17
Tangible Book Value
111.56151.46-71.67-38.41-12.48
Tangible Book Value Per Share
4.115.61-18.81-10.40-5.17
Machinery
2.582.751.271.20.88
Leasehold Improvements
0.250.25---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q